carbapenems has been researched along with minocycline in 165 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (minocycline) | Trials (minocycline) | Recent Studies (post-2010) (minocycline) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 6,579 | 502 | 2,921 |
| Protein | Taxonomy | carbapenems (IC50) | minocycline (IC50) |
|---|---|---|---|
| Multidrug transporter MdfA | Escherichia coli K-12 | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (10.91) | 29.6817 |
| 2010's | 142 (86.06) | 24.3611 |
| 2020's | 5 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, JF; Bronson, JJ | 1 |
| Gatward, T; Henwood, CJ; James, D; Livermore, DM; Spence, RP; Stockdale, MW; Towner, KJ; Warner, M; Woodford, N | 1 |
| Lynch, AS | 1 |
| Rice, LB | 1 |
| Hill, RL; Livermore, DM; Woodford, N | 1 |
| Noskin, GA; Obias, A; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, T | 1 |
| Cheong, HJ; Hwang, IS; Jeong, HW; Kee, SY; Kim, WJ; Seo, YB; Song, JY | 1 |
| Weigelt, JA | 1 |
| Brook, I | 2 |
| Kuti, JL; Nicasio, AM; Nicolau, DP | 1 |
| Carattoli, A; Fadda, G; Gona, F; Mezzatesta, ML; Nicoletti, G; Nicolosi, D; Nicolosi, VM; Stefani, S; Trovato, G | 1 |
| Choi, CH; Heo, ST; Jeong, YG; Jin, JS; Kim, JW; Kim, SJ; Lee, JC; Lee, YC | 1 |
| Arikan Akan, O; Uysal, S | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Pillai, P; Posti, J; Singhal, S | 1 |
| Al Hashem, G; Dehrab, N; Jamal, W; Rotimi, VO; Salama, M; Shahin, M | 1 |
| Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Johnson, JL | 1 |
| Baudry, PJ; Cox, L; Hoban, DJ; Karlowsky, JA; Tailor, F; Zhanel, GG | 1 |
| Giamarellou, H; Poulakou, G | 1 |
| Chen, LA; Cui, JC; Liu, YN | 1 |
| Cattoir, V; Daurel, C | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Devasahayam, G; Hoffman, PS; Scheld, WM | 1 |
| Alp, E; Aygen, B; Metan, G; Percin, D; Sumerkan, B; Yildiz, O | 1 |
| Otük, G; Ozbek, B | 1 |
| Hasan, R; Khan, E; Shakoor, S; Zafar, A | 1 |
| Andaluz, D; Bobillo, F; Domínguez-Gil, M; Eiros, JM; Ortiz de Lejarazu, R; Rodríguez-Molins, E; Tenorio-Abreu, A | 1 |
| Elborn, JS; Parkins, MD | 1 |
| Chan, MC; Chang, TY; Chiueh, TS; Sun, JR; Wang, WY | 1 |
| Curcio, D | 1 |
| Bonomo, RA; Patel, G; Perez, F | 1 |
| Akşit, F; Aybey, AD; Kiremitçi, A; Nayman Alpat, S; Ozgüneş, I; Usluer, G | 1 |
| Wilke, MH | 1 |
| Chen, YH; Hsueh, PR; Huang, YT; Ko, WC; Lai, CC; Liu, WL; Tan, HR | 1 |
| Bonomo, RA; Endimiani, A; Fraser, TG; Hall, GS; Neuner, EA; Sekeres, J; Shrestha, NK; van Duin, D; Yeh, JY | 1 |
| Engler, C; Harris, P; Norton, R | 1 |
| Hsu, LY; Kwa, AL; Lee, W; Lim, TP; Sasikala, S; Tan, TT; Tan, TY | 1 |
| Merino, P; Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
| Bogaerts, P; Bouchahrouf, W; de Castro, RR; Denis, O; Deplano, A; Glupczynski, Y; Tsobo, C | 1 |
| Guner, R; Hasanoglu, I; Kalem, AK; Keske, S; Tasyaran, MA | 1 |
| Ahmad, F; Bheemreddy, S; Blunden, C; Bonomo, RA; Campbell, M; Chen, TY; Chopra, T; Dhar, S; Hayakawa, K; Hujer, AM; Kaye, KS; Lephart, PR; Marchaim, D; Patel, D; Perez, F; Pogue, JM; Rudin, S; Salimnia, H; Shango, M; Slim, J; Varkey, J | 1 |
| Cai, JC; Chen, GX; Nasu, M; Zhang, R; Zhou, HW | 1 |
| Blumenthal, JS; Calfee, DP; Cohen, AB; Furuya, EY; Jenkins, SG; Kubin, CJ; Satlin, MJ; Wilson, SJ | 1 |
| Dowzicky, MJ; Namdari, H; Tan, TY | 1 |
| Chen, CM; Chen, WY; Chen, YH; Chen, YS; Cheng, YJ; Chiang, PC; Chuang, YC; Hsu, GJ; Hsueh, PR; Huang, CH; Jang, TN; Ko, WC; Kung, HC; Lee, CM; Lee, MH; Liao, CH; Lin, HC; Liu, CE; Liu, JW; Liu, YC; Lu, CT; Lu, PL; Pan, SC; Shi, ZY; Sun, W; Tsao, SM; Wang, LS; Yang, JL; Yu, KW | 2 |
| Bille, E; Carbonnelle, E; Cattoir, V; Corvec, S; Fihman, V; Illiaquer, M; Jacquier, H; Jauréguy, F; Le Monnier, A; Tankovic, J; Zahar, JR | 1 |
| Abreu-Lanfranco, O; Bhargava, A; Bheemreddy, S; Campbell, M; Chopra, T; Dhar, S; Hayakawa, K; Kaye, KS; Khandker, N; Ku, K; Lephart, PR; Marchaim, D; Martin, ET; Moshos, J; Pogue, JM; Wang, Y | 1 |
| Ahmed, NH; Baba, K; Clay, C; Hoosen, AA; Lekalakala, R | 1 |
| Cheng, A; Hsueh, PR; Huang, YT; Lee, YC; Liao, CH; Liu, CY; Tsai, HY | 1 |
| Chang, HH; Chung, DR; Heo, ST; Joung, MK; Jung, SI; Kang, CI; Kim, SW; Lee, JA; Moon, C; Moon, SY; Peck, KR; Ryu, SY; Shin, SY; Son, JS; Song, JH | 1 |
| Absar, MM; Al Aska, AI; Arshad, MZ; Fatani, AJ; Murray, TS; Shakoor, ZA; Siddiqui, YM; Somily, AM | 1 |
| Altouvas, G; Mamali, V; Pitiriga, V; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Tziraki, M; Zarkotou, O | 1 |
| Dowzicky, MJ; Fernández-Canigia, L | 1 |
| Garcés, C; Hurtado, IC; Mesa, JG; Restrepo, A; Tamayo, C; Trujillo, M | 1 |
| Casini, B; Costanzo, S; Leonetti, P; Leonildi, A; Malacarne, P; Menichetti, F; Sbrana, F; Tascini, C; Viaggi, B | 1 |
| Grover, N; Khajuria, A; Kumar, M; Praharaj, AK | 1 |
| Burgess, DS; Lee, GC | 1 |
| Giannella, M; Lewis, R; Petrosillo, N; Viale, P | 1 |
| Perez, F; Van Duin, D | 1 |
| Barber, KE; Kaye, KS; Mann, T; Pogue, JM | 1 |
| Bordi, E; Capone, A; D'Arezzo, S; Di Caro, A; Mazzarelli, A; Petrosillo, N; Principe, L | 1 |
| Kim, SY; Ko, KS; Shin, J; Shin, SY | 1 |
| Hagihara, M; Housman, ST; Kuti, JL; Nicolau, DP | 2 |
| Bonnin, RA; Nordmann, P; Poirel, L | 1 |
| Erdogan-Yildirim, Z; Manafi, M; Sauermann, R; Schwameis, R; Strommer, S; Zeitlinger, MA | 1 |
| Colon-Urban, R; Kopacz, J; Mariano, N; Segal-Maurer, S; Sychangco, P; Urban, C; Wehbeh, W | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F; Metan, G | 2 |
| Falagas, ME; Lourida, P; Poulikakos, P; Rafailidis, PI; Tansarli, GS | 1 |
| Kanafani, ZA; Kanj, SS; Kmeid, JG; Youssef, MM | 1 |
| Bulitta, JB; Landersdorfer, CB; Zavascki, AP | 1 |
| Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y | 1 |
| Barba, MJ; Bou, G; Merino, M; Poza, M; Roca, I; Sousa, MD; Vila, J | 1 |
| Fakih, MG; Goodell, M; Hartman, P; Hayakawa, K; Johnson, LE; Kaye, KS; Lephart, PR; Major, S; Malani, AN; Marchaim, D; Mody, L; Newton, DW; Painter, T; Perri, MB; Pogue, JM; Salimnia, H; Thyagarajan, RV; Tzuman, O; Washer, LL; Wholehan, JM; Zervos, MJ | 1 |
| Apisarnthanarak, A; Khawcharoenporn, T; Mundy, LM; Pruetpongpun, N; Rutchanawech, S; Tiamsak, P | 1 |
| Betts, JW; Hornsey, M; Phee, LM; Wareham, DW; Woodford, N | 1 |
| Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y | 1 |
| She, D; Wang, H; Wang, R | 1 |
| Bonomo, RA; Cline, M; Cober, ED; Evans, SR; Fowler, VG; Kalayjian, RC; Kaye, KS; Perez, F; Richter, SS; Salata, RA; van Duin, D | 1 |
| Caio, C; Cormaci, R; Denaro, C; Gennaro, M; Gona, F; Mezzatesta, ML; Quattrone, C; Salerno, I; Stefani, S; Zingali, T | 1 |
| Falagas, ME; Rafailidis, PI | 1 |
| Zurawski, RM | 1 |
| Kaye, KS; Lephart, P; Mynatt, RP; Neelakanta, A; Pogue, JM; Sharma, S | 1 |
| Fouzas, I; Gritsi-Gerogianni, N; Imvrios, G; Iosifidis, E; Kydona, C; Massa, E; Mouloudi, E; Papadopoulos, S; Papanikolaou, V; Piperidou, M; Roilides, I; Theodoridou, T | 1 |
| Mataraci-Kara, E; Ozbek Celik, B; Yilmaz, M | 1 |
| Chen, TL; Chow, SF; Liu, CP; Shih, SC; Sun, FJ; Wang, NY; Wu, AY; Yan, TR | 1 |
| Bassetti, M; Cavallo, R; Corcione, S; De Rosa, FG; Di Perri, G | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F | 1 |
| Chang, SC; Chen, YC; Cheng, A; Chuang, YC; Hsueh, PR; Hung, CC; Liao, CH; Shen, NJ; Sheng, WH; Sun, HY; Wang, JT; Yang, CJ; Yang, JL | 1 |
| Amaya-Villar, R; Díaz-Martín, A; Ferrándiz-Millón, C; Garnacho-Montero, J; Gutiérrez-Pizarraya, A; López-Sánchez, JM | 1 |
| Huan, J | 1 |
| Carvalhaes, CG; Cayô, R; Croda, J; Gales, AC; Patussi Correia Sacchi, F; Ramos da Silva, AC; Rodrigues-Costa, F; Silva, KE; Simionatto, S | 1 |
| Bonomo, RA; Spellberg, B | 1 |
| Antoniadou, E; Antypa, E; Falagas, ME; Koteli, A; Matthaiou, DK; Vardakas, KZ | 1 |
| Bonomo, RA; Cober, E; Evans, S; Fowler, VG; Kalayjian, RC; Kaye, KS; Perez, F; Richter, SS; Salata, RA; van Duin, D | 1 |
| Botziori, C; Kakasi, E; Koteli, A; Meletis, G; Oustas, E | 1 |
| Castanheira, M; Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Cakirlar, FK; Ciftci, IH; Gonullu, N | 1 |
| Anupurba, S; Banerjee, T; Filgona, J | 1 |
| Jaworowska, J; Jurczak, A; Majewski, P; Ojdana, D; Olszańska, D; Sacha, P; Sieńko, A; Tryniszewska, E; Wieczorek, P | 1 |
| Nabarro, LE; Veeraraghavan, B | 1 |
| Bassetti, M; Poulakou, G; Tsiodras, S | 1 |
| Abbo, LM; Aragon, L; Beduschi, T; Camargo, JF; Cantón, R; Morris, MI; Pérez-Cardona, A; Prado, CE; Simkins, J; Tekin, A | 1 |
| Aydin, M; Ceylan, MR; Cikman, A; Gulhan, B; Karagoz, A; Karakecili, F; Parlak, M | 1 |
| Antonelli, M; De Pascale, G | 1 |
| Corona, A | 1 |
| Butić, I; Cornaglia, G; Crnek, SŠ; Gužvinec, M; Kocsis, E; Krešić, S; Mazzariol, A; Tambić, A | 1 |
| Aguilar, L; Gilsanz, F; Gimenez, MJ; Maseda, E | 1 |
| Arora, R; Chakotiya, AS; Chawla, R; Goel, R; Narula, A; Sharma, RK; Tanwar, A; Thakur, P | 1 |
| Guo, Q; Sheng, ZK; Wang, M; Wang, W; Xu, X; Yang, Y | 1 |
| Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
| Choi, IS; Choi, JA; Jang, SJ; Jeong, SH; Kang, SH; Kim, CM; Moon, DS; Park, G; Park, GC | 1 |
| Seenama, C; Thamlikitkul, V; Tiengrim, S | 1 |
| Cui, J; Han, Y; Liu, J; Liu, Y; Ni, W; Wang, R; Wei, C; Zhao, J | 1 |
| Livermore, DM; Mushtaq, S; Warner, M; Woodford, N | 1 |
| Kumar, M | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Chang, CL; Huang, LF; Lee, CT; Su, LH | 1 |
| Al-Agamy, MH; Al-Qahtani, AA; El-Mahdy, TS; Shibl, AM | 1 |
| Chang, FY; Chen, TL; Chiu, CH; Chuang, MF; Kuo, SC; Lee, YT; Lin, JC; Wang, YC; Yang, YS | 1 |
| Dowzicky, MJ; Rodloff, AC | 1 |
| Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
| Dimitriadis, P; Malisiovas, N; Metallidis, S; Poulou, A; Pournaras, S; Protonotariou, E; Skoura, L; Tsakris, A; Varlamis, S; Vasilaki, O | 1 |
| Li, F; Li, P; Yin, Y; Zhang, Q; Zhang, Y | 1 |
| Huang, CT; Huang, PY; Lee, MH; Lin, HS; Wu, YM; Yang, CC; Ye, JJ; Yeh, CF | 1 |
| Anandan, S; Nabarro, LEB; Shankar, C; Veeraraghavan, B | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Adibhesami, H; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghourchian, S; Jasemi, S; Mohammadzadeh, M; Rahbar, M; Zeraati, H | 1 |
| Bowler, SL; Doi, Y; Guo, Y; Kantz, SF; McElheny, CL; Mettus, RT; Wang, P | 1 |
| Katsiari, M; Likousi, S; Mavroidi, A; Nikolaou, C; Palla, E; Platsouka, ED; Roussou, Z | 1 |
| Fu, Y; Liu, R; Pan, Z; Zhang, P; Zhou, H; Zhou, J | 1 |
| Goic-Barisic, I; Hrenovic, J; Kovacic, A; Seruga Music, M; Tonkic, M | 1 |
| Al-Agamy, MH; Courvalin, P; El-Mahdy, TS; Jeannot, K; Kattan, W; Plésiat, P; Shibl, AM | 1 |
| Camargo, CH; Casas, MRT; Garcia, DO; Tavares, LCB; Vasconcellos, FM | 1 |
| Altun, B; Altun, Ş; Demiröz, AP; Kınıklı, S; Koçak Tufan, Z; Önde, U | 1 |
| Ardebili, A; Mardaneh, J; Razavi Nikoo, H | 1 |
| Bahador, A; Ekrami, A; Savari, M; Shoja, S | 1 |
| Al-Abri, SS; Al-Jardani, A; Aldeesi, Z; Carattoli, A; Darwish, D; Ghazawi, A; Hashmey, R; Jamal, W; Pál, T; Rotimi, V; Sonnevend, Á; Villa, L | 1 |
| Li, P; Wang, W; Wang, X; Zhao, X | 1 |
| Carrilho, C; Costa, SF; Guimaraes, T; Levin, AS; Marchi, AP; Miranda, L; Rizek, C; Rosa, JF | 1 |
| Falagas, ME; Legakis, NJ; Skalidis, T; Vardakas, KZ | 1 |
| Chan, MC; Chang, FY; Chiu, SK; Huang, LY; Lin, JC; Lin, YT; Lu, PL; Siu, LK; Yeh, KM | 1 |
| Chang, FY; Chen, H; Chiu, SK; Huang, LY; Lin, JC; Liou, CH; Siu, LK; Tsai, YK; Yeh, KM | 1 |
| Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ | 1 |
| Hogardt, M; Kempf, VAJ; Kessel, J; Lange, CM; Mücke, MM; Mücke, VT; Schwarzkopf, K; Stephan, C; Zeuzem, S | 1 |
| Cha, MK; Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, JY; Lee, JH; Lee, NY; Park, GE; Peck, KR; Seok, H; Song, JH | 1 |
| Doi, Y; McElheny, CL; Mettus, RT; Shanks, RMQ; Wang, P | 1 |
| Li, Y; Liu, J; Liu, XJ; Lyu, Y; Xue, F | 1 |
| Ambretti, S; Bartoletti, M; Bartoloni, A; Bassetti, M; Cauda, R; Corcione, S; De Rosa, FG; Del Bono, V; Giacobbe, DR; Giannella, M; Lewis, RE; Losito, AR; Marchese, A; Raffaelli, F; Rossolini, GM; Saffioti, C; Spanu, T; Tedeschi, S; Trecarichi, EM; Tumbarello, M; Viale, P; Viscoli, C | 1 |
| Amat, T; Cisneros, JM; Garnacho-Montero, J; Gracia-Ahufinger, I; Gutiérrez-Pizarraya, A; Machuca, I; Pérez-Nadales, E; Torre-Cisneros, J; Torre-Giménez, Á | 1 |
| Bonnin, RA; Bouallegue, O; Boujaafar, N; Jaidane, N; Jerbi, S; Mansour, W; Naas, T; Radhia, BB | 1 |
| Huang, D; Jacobs, DM; Minhaj, F; Parker, A; Rao, GG; Safir, MC | 1 |
| Alavi-Moghaddam, M; Ghalavand, Z; Goudarzi, H; Houri, H; Nikmanesh, B; Salehi, B | 1 |
| Hu, L; Kong, Q; Li, J; Shen, J; Xu, X; Ye, Y; Zhang, Z; Zhou, Z | 1 |
| Gao, HH; Huang, S; Jing, Y; Li, Y; Liu, J; Yao, ZL | 1 |
| Cai, J; Chan, EW; Chen, S; Dong, N; Hu, Y; Huang, Y; Xie, M; Zhang, R; Zhou, H | 1 |
| Akova, M; Chen, T; Hua, X; Ji, S; Leptihn, S; Pi, B; Xu, Q; Yan, B; Yang, Y; Yu, Y; Zhang, L; Zhou, Z | 1 |
| Akinci, E; Baran, I; Bodur, H; Mumcuoglu, I; Sertcelik, A | 1 |
| Ahn, JY; Choi, H; Choi, JY; Choi, YH; Jeong, SJ; Kim, JM; Ku, NS; Lee, SH; Lim, YS; Shin, SJ; Song, YG; Yeom, JS; Yong, D | 1 |
| Jiang, Y; Mao, Y; Shi, Q; Yu, Y; Zhang, P | 1 |
| Alosaimy, S; Andrade, J; Biagi, M; Bouchard, J; Cosimi, R; Davis, SL; Gore, T; Hobbs, ALV; Huang, G; Jones, B; Kang-Birken, SL; King, MA; Lagnf, AM; Molina, KC; Morrisette, T; Perkins, NB; Pierce, M; Pullinger, BM; Rojas, LM; Rybak, MJ; Scipione, MR; Truong, J; Veve, MP; Zhao, JJ | 1 |
| Chen, CH; Ho, MW; Hsueh, PR; Lu, MC; Wu, PH | 1 |
| Bai, XR; Fan, L; Li, WC; Lou, R; Qu, X; Wang, YG; Wang, ZZ; Wu, YC; Yan, SY; Zhang, L; Zhang, W | 1 |
32 review(s) available for carbapenems and minocycline
| Article | Year |
|---|---|
Quinolone, everninomycin, glycylcycline, carbapenem, lipopeptide and cephem antibacterials in clinical development.
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Clinical Trials as Topic; Daptomycin; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Minocycline; Prodrugs; Tetracyclines; Tigecycline | 2001 |
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Biofilms; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Tigecycline | 2006 |
Empiric treatment options in the management of complicated intra-abdominal infections.
Topics: Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Doripenem; Drug Resistance, Bacterial; General Surgery; Humans; Internal Medicine; Minocycline; Peritoneal Cavity; Peritonitis; Risk Factors; Severity of Illness Index; Surgical Wound Infection; Tigecycline | 2007 |
Treatment of anaerobic infection.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Negative-Pressure Wound Therapy; Penicillins; Tigecycline | 2007 |
The current state of multidrug-resistant gram-negative bacilli in North America.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; North America; Polymyxins; Sulbactam; Tigecycline | 2008 |
Multidrug-resistant Gram-negative infections: what are the treatment options?
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline | 2009 |
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
Newer antibacterial drugs for a new century.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Delivery Systems; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Drugs, Investigational; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Macrolides; Minocycline; Oxazolidinones; Tigecycline | 2010 |
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cystic Fibrosis; Doripenem; Humans; Minocycline; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Stenotrophomonas maltophilia; Tigecycline | 2010 |
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Skin Diseases, Bacterial; Tigecycline; Treatment Outcome | 2010 |
Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Minocycline; Organ Transplantation; Risk Factors; Tigecycline | 2010 |
Multiresistant bacteria and current therapy - the economical side of the story.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Doripenem; Drug Resistance, Microbial; Drug Resistance, Multiple; Economics, Pharmaceutical; Linezolid; Minocycline; Oxazolidinones; Tigecycline | 2010 |
Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Combinations; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Polymyxins; Tigecycline; Treatment Outcome | 2012 |
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Therapy, Combination; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Rifampin; Risk Factors; Tigecycline | 2013 |
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Minocycline; Tigecycline | 2013 |
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Disease Management; Disease Outbreaks; Epidemiological Monitoring; Humans; Minocycline; Tigecycline | 2013 |
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression; Gene Transfer, Horizontal; Humans; Minocycline; Mutation; Tigecycline | 2013 |
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Critical Illness; Drug Therapy, Combination; Enterobacteriaceae; Humans; Minocycline; Pneumonia, Bacterial; Survival Analysis; Tigecycline; Urinary Tract Infections | 2014 |
Combination therapy for Gram-negative bacteria: what is the evidence?
Topics: Anti-Bacterial Agents; Carbapenems; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Combination therapy for carbapenem-resistant Gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Administration Schedule; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline | 2013 |
Options for treating carbapenem-resistant Enterobacteriaceae.
Topics: beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infection Control; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Practice Patterns, Physicians'; Prospective Studies; Retrospective Studies; Tigecycline; Treatment Outcome | 2014 |
Carbapenem-resistant enterobacteriaceae: occult threat in the intensive care unit.
Topics: Anti-Bacterial Agents; Carbapenems; Critical Care Nursing; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Infection Control; Intensive Care Units; Minocycline; Sepsis; Tigecycline | 2014 |
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Therapy, Computer-Assisted; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Risk Factors; Tigecycline | 2015 |
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Sulbactam; Tigecycline | 2015 |
Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case Management; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Microbial Sensitivity Tests; Minocycline; Observational Studies as Topic; Polymyxins; Randomized Controlled Trials as Topic; Tigecycline; Treatment Outcome | 2015 |
Basis for selecting optimum antibiotic regimens for secondary peritonitis.
Topics: Abdominal Cavity; Anti-Bacterial Agents; Candida; Candidiasis; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Peritonitis; Practice Guidelines as Topic; Risk Factors; Tigecycline | 2016 |
Spectrum and treatment of anaerobic infections.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cefoxitin; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Humans; Metronidazole; Minocycline; Penicillins; Tigecycline | 2016 |
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Minocycline; Tigecycline | 2016 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2017 |
Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Iran; Meropenem; Microbial Sensitivity Tests; Minocycline; Polymyxin B; Rifampin; Thienamycins; Tigecycline | 2017 |
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Combinations; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Pneumonia; Polymyxin B; Polymyxins; Tigecycline; Treatment Outcome; Urinary Tract Infections | 2017 |
133 other study(ies) available for carbapenems and minocycline
| Article | Year |
|---|---|
Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline; United Kingdom | 2002 |
Antibacterial Drug Discovery and Development Summit - Tenth Annual SRI Summit.
Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Design; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Iohexol; Macrolides; Microsomes; Minocycline; Technology, Pharmaceutical; Tigecycline | 2005 |
In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter spp.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacter; Klebsiella; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2007 |
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Infective Agents; Carbapenems; Drug Combinations; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2007 |
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Sulbactam; Tigecycline | 2007 |
In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Italy; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Tigecycline | 2008 |
Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Korea; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
[In vitro activity of tigecycline against multiple resistant Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae isolates].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2008 |
Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Quinolones; Salmonella; Salmonella Infections; Tigecycline; Typhoid Fever | 2009 |
Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Humans; Incidence; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Minocycline; Molecular Epidemiology; Tigecycline; Young Adult | 2009 |
Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Colombia; Drug Resistance, Bacterial; Greece; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Population Surveillance; Puerto Rico; Tigecycline | 2009 |
Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems us
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Models, Theoretical; Serum; Tigecycline | 2009 |
Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Mutation; Tigecycline | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Young Adult | 2010 |
In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Humans; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2010 |
In vitro activity of tigecycline and other tetracyclines against carbapenem-resistant Acinetobacter species: report from a tertiary care centre in Karachi, Pakistan.
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Pakistan; Tetracyclines; Tigecycline | 2010 |
[Variability in the sensitivity to tigecycline against Acinetobacter baumannii in different culture media].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Culture Media; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Reproducibility of Results; Tigecycline | 2010 |
Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Membrane Transport Proteins; Middle Aged; Minocycline; Molecular Sequence Data; Mutagenesis, Insertional; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline | 2010 |
[In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Microbial Sensitivity Tests; Minocycline; Nocardia; Quinolones; RNA, Ribosomal, 16S; Tigecycline | 2011 |
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Prognosis; Retrospective Studies; Tigecycline; Treatment Outcome | 2011 |
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Burkholderia pseudomallei; Carbapenems; Doripenem; Ertapenem; Fluoroquinolones; Humans; Melioidosis; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline | 2011 |
In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Microbial; In Vitro Techniques; Minocycline; Polymyxin B; Rifampin; Singapore; Tigecycline | 2011 |
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Chromosome Mapping; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Sequence Analysis, DNA; Tigecycline; Urinary Tract Infections | 2012 |
Detection of a VIM-27-producing Klebsiella pneumoniae isolate in a patient following surgical tourism in Greece.
Topics: Adult; Aztreonam; beta-Lactamases; Carbapenems; Colistin; Female; Gentamicins; Greece; Humans; Klebsiella pneumoniae; Medical Tourism; Minocycline; Plasmids; Tigecycline | 2011 |
Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Therapy, Combination; Drug Utilization; Female; Hospitals; Humans; Male; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome; Turkey; Young Adult | 2011 |
Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Colistin; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Hospital Mortality; Humans; Infant; Length of Stay; Male; Michigan; Middle Aged; Minocycline; Nursing Homes; Retrospective Studies; Tigecycline; Treatment Outcome; Young Adult | 2011 |
Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxin B; Sequence Analysis, DNA; Tigecycline | 2011 |
Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Polymyxin B; Retrospective Studies; Tigecycline; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult | 2011 |
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
Topics: Acetamides; Acinetobacter baumannii; Carbapenems; Drug Evaluation; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Humans; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Skin; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2012 |
Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline; Vancomycin | 2012 |
Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline; Vancomycin | 2012 |
In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2012 |
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cohort Studies; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Michigan; Middle Aged; Minocycline; Retrospective Studies; Severity of Illness Index; Survival Analysis; Tigecycline; Treatment Outcome | 2012 |
In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa.
Topics: Acinetobacter baumannii; Adult; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; South Africa; Tigecycline | 2012 |
Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Central Venous Catheters; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Taiwan; Tertiary Care Centers; Tigecycline | 2012 |
Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Coinfection; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Retrospective Studies; Survival Rate; Tigecycline | 2012 |
Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Tigecycline | 2012 |
Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2012 |
Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter; Escherichia coli; Imipenem; Klebsiella oxytoca; Klebsiella pneumoniae; Latin America; Meropenem; Microbial Sensitivity Tests; Minocycline; Serratia marcescens; Thienamycins; Tigecycline; United States; United States Food and Drug Administration | 2012 |
[Experience with tigecycline compassionate use in pediatric patients infected with carbapenem resistant Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child, Preschool; Compassionate Use Trials; Fatal Outcome; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Minocycline; Retrospective Studies; Tigecycline | 2012 |
Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Female; Gentamicins; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome | 2013 |
First report of blaNDM-1 in Raoultella ornithinolytica.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Male; Minocycline; Molecular Sequence Data; Tigecycline | 2013 |
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Tertiary Healthcare; Tigecycline | 2013 |
Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Mutation; Polymyxins; Porins; Republic of Korea; Tigecycline | 2013 |
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Minocycline; Models, Theoretical; Sulbactam; Tigecycline | 2013 |
Effect of pulmonary surfactant on antimicrobial activity in vitro.
Topics: Acetamides; Animals; Anti-Infective Agents; Aza Compounds; Carbapenems; Colistin; Daptomycin; Doripenem; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Oxazolidinones; Pulmonary Surfactants; Quinolines; Staphylococcus aureus; Swine; Tigecycline | 2013 |
Identification of extended-spectrum-β-lactamase-positive Klebsiella pneumoniae urinary tract isolates harboring KPC and CTX-M β-lactamases in nonhospitalized patients.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Fosfomycin; Humans; Klebsiella pneumoniae; Minocycline; Tigecycline; Urinary Tract | 2013 |
Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Methylprednisolone; Methylprednisolone Acetate; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Structure-Activity Relationship; Tigecycline | 2014 |
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline | 2013 |
In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colony Count, Microbial; Drug Combinations; Drug Synergism; Microbial Sensitivity Tests; Minocycline; Models, Statistical; Polymyxin B; Tigecycline | 2014 |
Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Spain; Survival Analysis; Tigecycline | 2014 |
Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Sulbactam; Tigecycline; Time Factors | 2013 |
Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Michigan; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2014 |
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Tigecycline; Treatment Outcome; Young Adult | 2014 |
In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Moths; Tigecycline | 2014 |
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins | 2014 |
Tigecycline minimum inhibitory concentration for carbapenem-resistant Acinetobacter baumannii by two methods.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2014 |
Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; Carbapenems; Cohort Studies; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Molecular Sequence Data; Sequence Analysis, DNA; Tigecycline | 2014 |
Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Italy; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Tigecycline | 2014 |
Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Michigan; Middle Aged; Minocycline; Pharmacy Service, Hospital | 2014 |
Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Follow-Up Studies; Greece; Humans; Incidence; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Minocycline; Pilot Projects; Prospective Studies; Risk Factors; Tigecycline; Time Factors; Treatment Outcome | 2014 |
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.
Topics: Carbapenems; Colistin; Doripenem; Dose-Response Relationship, Drug; Drug Combinations; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Minocycline; Rifampin; Tigecycline; Tobramycin | 2014 |
Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Minocycline; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Tigecycline | 2016 |
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline | 2015 |
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
Topics: Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Organ Dysfunction Scores; Prospective Studies; Taiwan; Tigecycline | 2015 |
[Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2015 |
Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Child, Preschool; Cross Infection; Disease Outbreaks; DNA, Bacterial; Female; Genes, Bacterial; Hospitals, Teaching; Humans; Infant; Integrons; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens; Tigecycline | 2015 |
Combination Therapy for Extreme Drug-Resistant Acinetobacter baumannii: Ready for Prime Time?
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
Topics: Aged; Carbapenems; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Tigecycline | 2015 |
Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Prospective Studies; Risk Factors; Skilled Nursing Facilities; Tigecycline; Time Factors | 2015 |
Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Containment of Biohazards; Cross Infection; Drug Resistance, Multiple, Bacterial; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tigecycline | 2015 |
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Europe; Humans; Microbial Sensitivity Tests; Minocycline; Multiplex Polymerase Chain Reaction; Sequence Analysis, DNA; Tigecycline | 2015 |
OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals, University; Humans; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multiplex Polymerase Chain Reaction; Tigecycline; Turkey | 2015 |
Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Tigecycline | 2015 |
First Report of Klebsiella pneumoniae-Carbapenemase-3-Producing Escherichia coli ST479 in Poland.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Tigecycline | 2015 |
"Excess Mortality" and Colistin-Tigecycline for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Colectomy; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Thienamycins; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Valganciclovir | 2015 |
In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Tigecycline; Young Adult | 2015 |
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough!
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Mortality and Extensively Drug Resistance: Drugs or Methods? That Is the Question!
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
blaNDM-1 Carriage on IncR Plasmid in Enterobacteriaceae Strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Citrobacter koseri; Colistin; Conjugation, Genetic; Croatia; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Expression; Gene Transfer, Horizontal; Humans; Isoenzymes; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Plasmids; Sequence Analysis, DNA; Tigecycline | 2016 |
Camellia sinensis Ameliorates the Efficacy of Last Line Antibiotics Against Carbapenem Resistant Escherichia coli.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactams; Camellia sinensis; Carbapenems; Colistin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Flavonoids; Free Radical Scavengers; Meropenem; Microbial Sensitivity Tests; Minocycline; Phytochemicals; Plant Extracts; Plant Leaves; Thienamycins; Tigecycline | 2016 |
Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multilocus Sequence Typing; Polymerase Chain Reaction; Tigecycline; Young Adult | 2016 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Tigecycline | 2016 |
Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Humans; Microbial Sensitivity Tests; Minocycline; Thailand | 2016 |
In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tetracyclines; Tigecycline | 2016 |
Colistin and Tigecycline Resistance in Carbapenem-Resistant Enterobacteriaceae: Checkmate to Our Last Line Of Defense.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2016 |
A Snapshot of Co-Resistance to Carbapenems and Tigecycline in Clinical Isolates of Enterobacter cloacae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Clone Cells; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Multidrug Resistance-Associated Proteins; Multilocus Sequence Typing; Porins; Taiwan; Tigecycline | 2017 |
Detection of bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Minocycline; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Public Health Surveillance; Saudi Arabia; Tigecycline | 2017 |
Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biofilms; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2016 |
Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014).
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Thienamycins; Tigecycline | 2017 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Humans; Microbial Sensitivity Tests; Minocycline | 2016 |
In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.
Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline | 2017 |
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Tigecycline; Treatment Outcome | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Minocycline; Sulbactam; Tigecycline; Tobramycin | 2016 |
Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Doxycycline; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2016 |
Investigation of Extensively Drug-Resistant blaOXA-23-Producing Acinetobacter baumannii Spread in a Greek Hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Greece; Hospitals; Humans; Intensive Care Units; Male; Membrane Transport Proteins; Microbial Sensitivity Tests; Middle Aged; Minocycline; Mutation; Retrospective Studies; Survival Analysis; Tigecycline; Transcription Factors | 2017 |
Combination of Tigecycline and Levofloxacin for Successful Treatment of Nosocomial Pneumonia Caused by New Delhi Metallo-β-Lactamase-1-Producing Raoultella planticola.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Gene Expression; Humans; Levofloxacin; Male; Minocycline; Plasmids; Polymerase Chain Reaction; Sputum; Tigecycline; Treatment Outcome | 2017 |
Pan Drug-Resistant Environmental Isolate of Acinetobacter baumannii from Croatia.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Croatia; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Humans; Microbial Sensitivity Tests; Minocycline; Phylogeny; Plasmids; Polymyxins; Tigecycline; Wastewater | 2017 |
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Saudi Arabia; Serogroup; Tigecycline | 2017 |
In vitro activity of antimicrobial agents against multidrug- and extensively drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins | 2017 |
Growing OXA-23 type strains among carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2016 |
Plasmid borne Carbapenem-Hydrolyzing Class D β-Lactamases (CHDLs) and AdeABC efflux pump conferring carbapenem-tigecycline resistance among Acinetobacter baumannii isolates harboring TnAbaRs.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biological Transport; Carbapenems; Conjugation, Genetic; Genetic Variation; Genotype; Hydrolysis; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Molecular Typing; Plasmids; Tigecycline | 2017 |
Characterization of NDM-7 Carbapenemase-Producing Escherichia coli Isolates in the Arabian Peninsula.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Gene Expression; Humans; Kuwait; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Oman; Phylogeny; Plasmids; Saudi Arabia; Tigecycline; United Arab Emirates | 2017 |
Comparison of the efficacies of three empirically-selected antibiotics for treating Acinetobacter baumannii pulmonary infection: experience from a teaching hospital in China
.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefoperazone; China; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Male; Middle Aged; Minocycline; Respiratory Tract Infections; Retrospective Studies; Sputum; Sulbactam; Tigecycline; Time Factors; Treatment Outcome | 2017 |
Clonality, outer-membrane proteins profile and efflux pump in KPC- producing Enterobacter sp. in Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacteriaceae Infections; Female; Fosfomycin; Genes, Bacterial; Hospitals; Humans; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Minocycline; Polymerase Chain Reaction; Polymyxin B; Tigecycline; Young Adult | 2017 |
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inpatients; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Thienamycins; Tigecycline | 2017 |
Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biological Transport; Carbapenems; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Real-Time Polymerase Chain Reaction; Tigecycline; Urinary Tract Infections | 2017 |
Roles of
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Multidrug Resistance-Associated Proteins; Mutation; Plasmids; Tetracycline Resistance; Tigecycline; Trans-Activators | 2017 |
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline | 2017 |
The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Germany; Gram-Negative Bacteria; Humans; Liver Abscess, Pyogenic; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome; Vancomycin Resistance | 2017 |
Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Disease Susceptibility; Drug Resistance, Bacterial; Female; Humans; Immunocompromised Host; Male; Middle Aged; Minocycline; Risk Factors; Tigecycline | 2017 |
Contribution of the TetB Efflux Pump to Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii Strains.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Doxycycline; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Tetracycline Resistance | 2017 |
Trends in Antimicrobial Resistance against Enterobacteriaceae Strains Isolated from Blood: A 10-year Epidemiological Study in Mainland China (2004-2014).
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; China; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2017 |
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
Topics: Aged; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Propensity Score; Tertiary Care Centers; Tigecycline; Treatment Outcome | 2018 |
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Cohort Studies; Colistin; Critical Illness; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Propensity Score; Survival Analysis; Tigecycline; Treatment Outcome | 2018 |
Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Middle Aged; Minocycline; Polymorphism, Single Nucleotide; Rifampin; Tigecycline; Transcription Factors | 2018 |
Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Communicable Diseases, Emerging; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals, Teaching; Humans; Intensive Care Units; Iran; Minocycline; Molecular Typing; Tigecycline | 2018 |
[The profile of antibiotic resistantpathogens isolated from ascites fluid patients in intensive care unit during past 12 years.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ascites; Bacteria; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Retrospective Studies; Tigecycline | 2016 |
[Safety and Effectiveness of High Dose Tigecycline for Treating Patients with Acute Leukemia after Ineffctiveness of Carbapenems Chemotherapy Combinating with Febrile Neutropenia: Retrospective study].
Topics: Anti-Bacterial Agents; Carbapenems; Febrile Neutropenia; Humans; Minocycline; Retrospective Studies; Tigecycline | 2018 |
Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carbapenems; Caspofungin; Colistin; Diarrhea; Drug Resistance, Bacterial; Echinocandins; Feces; Gastrointestinal Tract; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leukemia, Monocytic, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Minocycline; Tigecycline; Treatment Outcome | 2018 |
Dual Role of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Lepidoptera; Microbial Sensitivity Tests; Minocycline; Tigecycline; Virulence | 2019 |
Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Minocycline; Sulbactam; Vancomycin | 2020 |
In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Fosfomycin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline | 2019 |
Effect of ramR loss-of-function insertion on tigecycline resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.
Topics: Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Minocycline; Tigecycline | 2020 |
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline | 2022 |
Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Leadership; Meropenem; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2023 |
Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Fibrinogen; Gram-Negative Bacteria; Humans; Intensive Care Units; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Tigecycline; Treatment Outcome | 2023 |